• 1
    D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 2007; 369:587596.
  • 2
    Borchers AT, Leibushor N, Naguwa SM, Cheema GS, Shoenfeld Y, Gershwin ME. Lupus nephritis: a critical review. Autoimmun Rev 2012; 12:174194.
  • 3
    Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999; 10:413424.
  • 4
    Boucher A, Droz D, Adafer E, Noël LH. Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 1986; 29:10431049.
  • 5
    Alexopoulos E, Seron D, Hartley RB, Cameron JS. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990; 37:100109.
  • 6
    de Zubiria Salgado A, Herrera-Diaz C. Lupus nephritis: an overview of recent findings. Autoimmune Dis 2012; 2012:Article ID 849684, 21 pp.
  • 7
    Castiglione A, Bucci A, Fellin G, d'Amico G, Atkins RC. The relationship of infiltrating renal leucocytes to disease activity in lupus and cryoglobulinaemic glomerulonephritis. Nephron 1988; 50:1423.
  • 8
    Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther 2011; 13:250259.
  • 9
    Zoja C, Liu XH, Donadelli R et al. Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J Am Soc Nephrol 1997; 8:720729.
  • 10
    Moore KJ, Wada T, Barbee SD, Kelley VR. Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice. Kidney Int 1998; 53:16311641.
  • 11
    Pérez de Lema G, Maier H, Nieto E et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 2001; 12:13691382.
  • 12
    Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med 1999; 190:18131824.
  • 13
    Ben-David Y, Giddens EB, Letwin K et al. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Rev 1991; 5:908918.
  • 14
    Watson DK, Smyth FE, Thompson DM et al. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ 1992; 3:705713.
  • 15
    Seth A, Ascione R, Fisher RJ, Mavrothalassitis GJ, Bhat NK, Papas TS. The ets gene family. Cell Growth Differ 1992; 3:327334.
  • 16
    Karim FD, Urness LD, Thummel CS et al. The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes Dev 1990; 4:14511453.
  • 17
    Hsu T, Trojanowska M, Watson DK. Ets proteins in biological control and cancer. J Cell Biochem 2004; 91:896903.
  • 18
    Papas TS, Bhat NK, Spyropoulos DD et al. Functional relationships among ETS gene family members. Leukemia 1997; 11 (Suppl 3):557566.
  • 19
    Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006; 54:385395.
  • 20
    Spyropoulos DD, Pharr PN, Lavenburg KR et al. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 2000; 20:56435652.
  • 21
    Georgiou P, Maroulakou IG, Green JE et al. Expression of ets family of genes in systemic lupus erythematosus and Sjogren's syndrome. Int J Oncol 1996; 9:918.
  • 22
    Zhang L, Eddy A, Teng TT et al. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol Cell Biol 1995; 15:69616970.
  • 23
    Zhang XK, Gallant S, Molano I et al. Decreased expression of the ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J Immunol 2004; 173:64816489.
  • 24
    Mathenia J, Reyes-Cortes E, Williams S et al. Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice. Clin Exp Immunol 2012; 362:362371.
  • 25
    Suzuki E, Karam E, Williams S, Watson DK, Gilkeson G, Zhang XK. Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney. Clin Immunol 2012; 145:201208.
  • 26
    Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. ‘Green mice’ as a source of ubiquitous green cells. FEBS Lett 1997; 407:313319.
  • 27
    Adalid-Peralta L, Mathian A, Tran T et al. Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis. Kidney Int 2008; 73:172180.
  • 28
    Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347:669671.
  • 29
    Fu Q, Chen X, Cui H et al. Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients. Arthritis Res Ther 2008; 10:R112.
  • 30
    Wada T, Furuichi K, Segawa-Takaeda C et al. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 1999; 56:9951003.
  • 31
    Liu ZH, Chen SF, Zhou H, Chen HP, Li LS. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis. Nephrol Dial Transplant 2003; 18:15261534.
  • 32
    Svenson JL, EuDaly J, Ruiz P, Korach KS, Gilkeson GS. Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin Immunol 2008; 128:259268.
  • 33
    Gladman DD, Urowitz MB, Keystone EC. Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. Am J Med 1979; 66:210215.
  • 34
    Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349:15261533.
  • 35
    Pérez de Lema G, Maier H, Franz TJ et al. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. J Am Soc Nephrol 2005; 16:35923601.
  • 36
    Turner JE, Paust HJ, Bennstein SB et al. Protective role for CCR5 in murine lupus nephritis. Am J Physiol Renal Physiol 2012; 302:F15031515.
  • 37
    Richard EM, Thiyagarajan T, Bunni MA et al. Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism. PLOS ONE 2013; 8:e75175. doi:10.1371/journal.pone.0075175.
  • 38
    Miyagi T, Yamaguchi K. Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology 2012; 22:880896.